Sort   by:  
 Page size 
UnknownStandard complete blood count to predict long-term outcomes in febrile infection-related epilepsy syndrome (FIRES): A multicenter study.
Not available
S-EPMC12779312 | biostudies-literature
UnknownA new congenital multicore titinopathy associated with fast myosin heavy chain deficiency.
Not available
S-EPMC7261750 | biostudies-literature
UnknownGenotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
Not available
S-EPMC4738459 | biostudies-literature
UnknownSingle-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.
Not available
S-EPMC10891320 | biostudies-literature
UnknownCongenital Titinopathies Linked to Mutations in TTN Metatranscript-Only Exons.
Not available
S-EPMC11641062 | biostudies-literature
UnknownAn Integrated Clinical-Biological Approach to Identify Interindividual Variability and Atypical Phenotype-Genotype Correlations in Myopathies: Experience on A Cohort of 156 Families.
Not available
S-EPMC8392536 | biostudies-literature
UnknownMetformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC12261116 | biostudies-literature
UnknownDifferences in Prevalence and Incidence of Electrocardiogram Abnormalities and Cardiovascular Autonomic Neuropathy Among Randomized Glucose-Lowering Treatments in Early Type 2 Diabetes: The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort.
Not available
S-EPMC12583396 | biostudies-literature
UnknownTime to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC11581631 | biostudies-literature
UnknownHigher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC10656670 | biostudies-literature
Sort   by:  
 Page size